| Income Statement |
| Total Revenue | 888.00K |
|
| Revenues (USD) | 888.00K |
| Cost of Revenue | 229.00K |
| Gross Profit | 659.00K |
| Operating Expenses | 4.21M |
| Research and Development Expense | 1.45M |
| Selling, General and Administrative Expense | 2.78M |
| Operating Income | -3.55M |
| Interest Expense | 11.00K |
| Net Income | -3.56M |
| Net Income Common Stock | -3.56M |
| Net Income Common Stock (USD) | -3.56M |
| Consolidated Income | -3.56M |
| Earnings per Basic Share | -0.18 |
| Earnings per Basic Share (USD) | -0.18 |
| Earnings per Diluted Share | -0.18 |
| Earning Before Interest & Taxes (EBIT) | -3.55M |
| Earning Before Interest & Taxes (USD) | -3.55M |
| Weighted Average Shares | 20.27M |
| Weighted Average Shares Diluted | 20.27M |
| Balance Sheet |
| Cash and Equivalents | 1.37M |
| Cash and Equivalents (USD) | 1.37M |
| Trade and Non-Trade Receivables | 37.00K |
| Current Assets | 2.01M |
| Property, Plant & Equipment Net | 5.68M |
| Total Assets | 7.94M |
| Debt Current | 273.00K |
| Total Debt | 1.63M |
| Current Liabilities | 2.89M |
| Debt Non-Current | 1.35M |
| Total Liabilities | 4.24M |
| Accumulated Retained Earnings (Deficit) | -130.63M |
| Accumulated Other Comprehensive Income | -43.00K |
| Shareholders Equity | 3.70M |
| Shareholders Equity (USD) | 3.70M |
| Assets Non-Current | 5.93M |
| Total Debt (USD) | 1.63M |
| Deferred Revenue | 1.04M |
| Liabilities Non-Current | 1.35M |
| Trade and Non-Trade Payables | 1.05M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 405.00K |
| Net Cash Flow from Financing | -185.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.26M |
| Capital Expenditure | -252.00K |
| Issuance (Purchase) of Equity Shares | -3.00K |
| Issuance (Repayment) of Debt Securities | -41.00K |
| Net Cash Flow from Investing | -252.00K |
| Net Cash Flow from Operations | -1.82M |
| Share Based Compensation | 129.00K |